Table 2 Differential expression of MYO10 is an independent predictor of survival in squamous cell carcinoma patients.

From: Expression ratio of the TGFβ-inducible gene MYO10 is prognostic for overall survival of squamous cell lung cancer patients and predicts chemotherapy response

variable

Multivariate analysis of overall survival

LUAD patients, n = 211

LUSC patients n = 151

HR (95% CI)

P-value

HR (95% CI)

P-value

MYO10 ratio (up- vs. down-regulation)

1.008 (0.967–1.050)

0.71

1.012 (1.006–1–018)

<0.001

Gender (m vs. f)

1.405 (0.832–2.373)

0.204

1.750 (0.75–4.083)

0.195

Age

1.005 (0.979–1.033)

0.695

1.032 (0.999–1.066)

0.06

pStage (II vs. I)

2.372 (1.120–5.025)

0.024

2.135 (1.010–4.513)

0.047

pStage (III vs. I)

4.966 (2.382–10.353)

<0.001

4.613 (2.169–9.811)

<0.001

Back to article page